Literature DB >> 30665553

Clinical presentation and management of hypoparathyroidism.

Gemma Marcucci1, Luisella Cianferotti2, Maria Luisa Brandi3.   

Abstract

The clinical manifestations of hypoparathyroidism are variable and can involve almost any organ system. The main clinical features of the hypoparathyroidism are typically signs or symptoms due to neuromuscular irritability owing to low serum calcium level. In addition to hypocalcemia, hyperphosphatemia can contribute to long-term complications, including extra-skeletal calcifications. Bone turnover markers are generally decreased, and bone mass density is usually normal-increased compared to age- and gender-matched controls. It is still unclear whether or not these bone features could have an impact on the risk of fracture. Impaired renal function is a common complication described in patients treated for hypoparathyroidism. Other complications include premature cataracts, seizures, basal ganglia calcifications, and cardiac arrhythmias. Lastly, some clinical studies have also reported a reduced quality of life of patients with hypoparathyroidism. Increased awareness of the clinical manifestations of this disease is important to improve its clinical management.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  hypocalcemia; hypoparathyroidism; symptomatology

Mesh:

Substances:

Year:  2018        PMID: 30665553     DOI: 10.1016/j.beem.2018.09.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  8 in total

Review 1.  Role of Phosphate in Biomineralization.

Authors:  Sanjay Kumar Bhadada; Sudhaker D Rao
Journal:  Calcif Tissue Int       Date:  2020-07-25       Impact factor: 4.333

Review 2.  Diagnosis and management of hypocalcemia.

Authors:  Jessica Pepe; Luciano Colangelo; Federica Biamonte; Chiara Sonato; Vittoria Carmela Danese; Veronica Cecchetti; Marco Occhiuto; Valentina Piazzolla; Viviana De Martino; Federica Ferrone; Salvatore Minisola; Cristiana Cipriani
Journal:  Endocrine       Date:  2020-05-04       Impact factor: 3.633

Review 3.  Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations.

Authors:  V Bonavolontà; L Cianferotti; G Iolascon; A Moretti; M L Brandi; F Fischetti; A Lenzi; C Baldari; S Migliaccio
Journal:  J Endocrinol Invest       Date:  2022-02-05       Impact factor: 4.256

4.  Association between total type I collagen N-terminal propeptide and coronary artery disease risk score in the general Japanese population.

Authors:  Hiroto Kikuchi; Takahito Nasu; Mamoru Satoh; Yuka Kotozaki; Kozo Tanno; Koichi Asahi; Hideki Ohmomo; Takamasa Kobayashi; Satoru Taguchi; Yoshihiro Morino; Atsushi Shimizu; Kenji Sobue; Makoto Sasaki
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-19

5.  Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report.

Authors:  Li-Na Ding; Yi Wang; Jun Tian; Li-Fang Ye; Shi Chen; Shi-Min Wu; Wen-Bin Shang
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

6.  EPILEPTIC SEIZURES AS THE FIRST MANIFESTATION OF FAHR'S SYNDROME.

Authors:  M M Manea; A Sirbu; D Dragos; A M Dobri; A G Sirbu; S Tuta
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

Review 7.  Phosphate Metabolism and Pathophysiology in Parathyroid Disorders and Endocrine Tumors.

Authors:  Guido Zavatta; Paola Altieri; Giulia Vandi; Valentina Vicennati; Uberto Pagotto; Fabio Vescini
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

8.  Seizures and Basal Ganglia Calcification Caused by Hypoparathyroidism.

Authors:  Tabinda Nageen; Syed Zaki Muhammad; Ammarah Jamal
Journal:  Cureus       Date:  2020-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.